Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

CTMXCTMX
30 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in CYTOMX THERAPEUTICS INC.

CITADEL ADVISORS LLC holds 3.1M shares of CTMX (CYTOMX THERAPEUTICS INC.), worth $11.7M as of 2026-Q2. The position was decreased (-42.5% shares). CTMX represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$11.7M

Current Shares

3.1M

Total Value Change

+$11.3M

Total Shares Change

+3.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
3.1M
-42.5%
$11.7M0.0%$3.75
0
2026-Q1
Increased
5.4M
+1479.3%
$25.4M0.0%$4.81
46
2025-Q4
Decreased
342,304
-81.0%
$1.5M0.0%$4.16
0
2025-Q3
Increased
1.8M
+2005.5%
$5.7M0.0%$3.23
44
2025-Q2
Increased
85,509
+854x
$194,1050.0%$2.25
25
2025-Q1
Decreased
100
-100.0%
$640.0%$0.63
0
2024-Q4
Increased
322,311
+1.6%
$331,9800.0%$1.02
24
2024-Q3
Decreased
317,119
-35.9%
$374,2000.0%$1.20
0
2024-Q2
Increased
494,643
+1245.0%
$603,4640.0%$1.22
39
2024-Q1
Decreased
36,777
-85.5%
$80,1740.0%$2.18
0
2023-Q4
Increased
253,283
+321.0%
$392,5880.0%$1.55
38
2023-Q3
Increased
60,166
+579.5%
$77,6140.0%$1.29
23
2023-Q2
Decreased
8,854
-96.8%
$15,2290.0%$1.41
0
2023-Q1
Decreased
278,677
-39.1%
$420,8030.0%$1.48
0
2022-Q4
Increased
457,918
+831.5%
$732,6690.0%$1.60
40
2022-Q3
Decreased
49,159
-85.4%
$71,0000.0%$1.47
0
2022-Q2
Increased
335,989
+2236.2%
$615,0000.0%$1.87
39
2022-Q1
Decreased
14,382
-62.2%
$38,0000.0%$2.77
0
2021-Q4
New
38,070
-
$165,0000.0%$4.40
34
2021-Q3
Exited
0
-100.0%
$00.0%$4.93
0
2021-Q2
Decreased
769,766
-17.2%
$4.9M0.0%$6.47
0
2021-Q1
Increased
929,910
+401.9%
$7.2M0.0%$7.40
44
2020-Q4
Decreased
185,266
-34.0%
$1.2M0.0%$6.82
0
2020-Q3
Increased
280,926
+312.7%
$1.9M0.0%$6.69
42
2020-Q2
Decreased
68,065
-66.3%
$567,0000.0%$8.21
0
2020-Q1
Decreased
202,106
-53.6%
$1.6M0.0%$6.70
0
2019-Q4
Increased
435,569
+87.4%
$3.6M0.0%$8.29
42
2019-Q3
New
232,475
-
$1.7M0.0%$7.70
36
2019-Q2
Exited
0
-100.0%
$00.0%$11.22
0
2019-Q1
New
34,290
-
$368,0000.0%$10.75
33

Other major holders of CTMX: FMR LLC, BlackRock, Inc., BNP PARIBAS FINANCIAL MARKETS

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used